SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy and safety of SOX regimen (S-1 plus
oxaliplatin) as salvage treatment in patients with relapsed or metastatic nasopharyngeal
carcinoma.